Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.

White-Gilbertson S, Lu P, Norris JS, Voelkel-Johnson C.

J Lipid Res. 2019 Apr 15. pii: jlr.M092247. doi: 10.1194/jlr.M092247. [Epub ahead of print]

2.

Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Lu P, White-Gilbertson S, Nganga R, Kester M, Voelkel-Johnson C.

Cancer Biol Ther. 2019;20(6):922-930. doi: 10.1080/15384047.2019.1579962. Epub 2019 Mar 5.

PMID:
30836822
3.

Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Voelkel-Johnson C, Norris JS, White-Gilbertson S.

Adv Cancer Res. 2018;140:265-293. doi: 10.1016/bs.acr.2018.04.014. Epub 2018 Jun 20.

4.

Prognostic Factors in Myoepithelial Carcinoma of the Major Salivary Glands.

Xiao CC, Baker AB, White-Gilbertson SJ, Day TA.

Otolaryngol Head Neck Surg. 2016 Jun;154(6):1047-53. doi: 10.1177/0194599816637605. Epub 2016 Apr 5.

PMID:
27048677
5.

Sex differences in the MB49 syngeneic, murine model of bladder cancer.

White-Gilbertson S, Davis M, Voelkel-Johnson C, Kasman LM.

Bladder (San Franc). 2016;3(1). pii: e22. Epub 2016 Feb 26.

6.

Regulated lysosomal exocytosis mediates cancer progression.

Machado E, White-Gilbertson S, van de Vlekkert D, Janke L, Moshiach S, Campos Y, Finkelstein D, Gomero E, Mosca R, Qiu X, Morton CL, Annunziata I, d'Azzo A.

Sci Adv. 2015 Dec 18;1(11):e1500603. doi: 10.1126/sciadv.1500603. eCollection 2015 Dec.

7.

Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients.

Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA.

Otolaryngol Head Neck Surg. 2016 Jan;154(1):121-30. doi: 10.1177/0194599815607449. Epub 2015 Sep 29.

PMID:
26419838
8.

Analysis of the National Cancer Data Base to Describe Treatment Trends in Stage IV Oral Cavity and Pharyngeal Cancers in the United States, 1998-2012.

White-Gilbertson S, Nelson S, Zhan K, Xiao C, Cope L, Day T.

J Registry Manag. 2015 Winter;42(4):146-51; quiz 156-7.

PMID:
26938651
9.

A primer on molecular biology for certified tumor registrars.

White Gilbertson S, Gosnell H, Cope L.

J Registry Manag. 2014 Spring;41(1):38-41. Review.

PMID:
24893187
10.

Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma.

Hua Y, White-Gilbertson S, Kellner J, Rachidi S, Usmani SZ, Chiosis G, Depinho R, Li Z, Liu B.

Clin Cancer Res. 2013 Nov 15;19(22):6242-51. doi: 10.1158/1078-0432.CCR-13-2083. Epub 2013 Sep 27.

11.

The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis.

White-Gilbertson S, Hua Y, Liu B.

Front Genet. 2013 Jun 11;4:109. doi: 10.3389/fgene.2013.00109. eCollection 2013.

12.

Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins.

White-Gilbertson SJ, Kasman L, McKillop J, Tirodkar T, Lu P, Voelkel-Johnson C.

J Urol. 2009 Sep;182(3):1178-85. doi: 10.1016/j.juro.2009.05.005. Epub 2009 Jul 21.

13.

The role of protein synthesis in cell cycling and cancer.

White-Gilbertson S, Kurtz DT, Voelkel-Johnson C.

Mol Oncol. 2009 Dec;3(5-6):402-8. doi: 10.1016/j.molonc.2009.05.003. Epub 2009 Jun 11. Review.

14.

Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells.

White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L, Voelkel-Johnson C.

Oncogene. 2009 Feb 26;28(8):1132-41. doi: 10.1038/onc.2008.468. Epub 2009 Jan 12.

15.

Transformation, translation and TRAIL: an unexpected intersection.

White-Gilbertson S, Rubinchik S, Voelkel-Johnson C.

Cytokine Growth Factor Rev. 2008 Apr;19(2):167-72. doi: 10.1016/j.cytogfr.2008.01.007. Review.

Supplemental Content

Loading ...
Support Center